Anti-livin antibodies: novel markers of malignant gastrointestinal cancers
نویسندگان
چکیده
منابع مشابه
Anti-angiogenic therapy against gastrointestinal tract cancers.
Gastrointestinal tract cancers constitute a group of highest morbidity both in and outside Japan, and the prognosis still remains unfavorable when the disease has progressed to the unresectable stage. Since the late 1990s, a novel category of anti-cancer drugs, 'molecular-targeted drugs', has become available, and angiogenesis has been considered as one of the most important molecular targets f...
متن کاملMalignant Potential of Gastrointestinal Cancers Assessed by Structural Equation Modeling
BACKGROUND Parameters reported in pathologic reviews have been failing to assess exactly the malignant potential of gastrointestinal cancers. We hypothesized that malignant potential could be defined by common latent variables (hypothesis I), but there are substantial differences in the associations between malignant potential and pathologic parameters according to the origin of gastrointestina...
متن کاملOverview of Gastrointestinal Cancers
Cancers of the gastrointestinal (GI) tract include those of the esophagus, stomach, colon, rectum, and anus. Risk factors, incidence, prevalence, and prognosis vary for each site. Many of the risk factors are modifiable, and in a significant number of cases, the cancers are preventable with proper screening and curable when detected and treated at an early stage. Esophageal cancer is a treatabl...
متن کاملHuman anti-IgM iso-antibodies: detection of IgM allotypic markers.
IgG class antibodies against human IgM were detected in a human subject up to a titer of 1:1024 against 5 of a group of 23 monoclonal Waldenström macroglobulins. Inhibition studies confirmed at least one antigenic determinant shared by the 5 IgMs. The determinant was present on the mu chain but required tertiary structure for its full expression. Inhibition of the reaction between the antibodie...
متن کاملImmunotherapy in Gastrointestinal Cancers
Gastrointestinal cancers represent a major public health problem worldwide. Immunotherapeutic strategies are currently under investigation in this setting and preliminary results of ongoing trials adopting checkpoint inhibitors are striking. Indeed, although a poor immunogenicity for GI has been reported, a strong biological rationale supports the development of immunotherapy in this field. The...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Polish Archives of Internal Medicine
سال: 2010
ISSN: 1897-9483
DOI: 10.20452/pamw.873